This episode’s Community Champion Sponsor is Ensemble Health Partners. To learn more about their inspiring work: CLICK HERE
Access to healthcare has not been equal for our nation's citizens and is now further exacerbated and pronounced amid this pandemic.
In today's episode, we are joined by Dr. Jag Singh to discuss the stark realities of the lack of access to virtual care for minority groups and the disenfranchised during the Coronavirus outbreak.
Dr. Singh is a Professor of Medicine at Harvard Medical School and served as the Clinical Director of the Cardiology Division from 2015 to 2020. He is also the Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program at the Massachusetts General Hospital Heart Center.
While together, Dr. Singh shares the early findings from his institution's study regarding the lack of access to virtual care and the direct negative impact it is having on many of our fellow Americans. Dr. Singh also shares valuable and insightful recommendations for our industry leaders to be contemplating to fix this crisis.
Additionally, Dr. Singh and I discuss the future of connected care, sensor technologies, and what innovation will mean for patients moving forward.
Join us for this frank, candid, and critical conversation as we continue to work together to move our nation's health forward.
Episode Highlights:
- Dr. Singh’s background and work during the pandemic
- Why virtual care is not accessible to all
- How to solve accessibility issues
- Reasons why internet should be a human right
- What role government should play in virtual care
- What does healthcare look like after the pandemic
- The future of sensors and the connected patient
About our Guest:
Dr. Jag Singh is a Professor of Medicine at Harvard Medical School. He has served as the Clinical Director of the Cardiology Division and the Roman W. DeSanctis Endowed Chair in Cardiology (2015-2020). He is the Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program, at the Massachusetts General Hospital Heart Center. Dr. Singh received his medical degree from BJ Medical College, Pune University, India. He completed his internal medicine residency, cardiology and cardiac electrophysiology fellowships at Mass General Hospital. He also earned a doctorate from Oxford University, a Master of science in clinical investigation from MIT-Harvard and a research fellowship at the Framingham Heart Study.
Dr. Singh is a well-recognized scientist and educator and has given over 300 lectures at multiple national and international conferences over the last few years. He is a fixture on numerous educational panels and a speaker at several ‘Meet the Masters’ and ‘Meet the Expert’ sessions at national and international conferences. He has served as the program director of over 30 educational symposia.
Dr. Singh's research interests are in clinical cardiac electrophysiology. He is the national & global principal investigator on 4 ongoing multi-center clinical trials in device therapy and sensor strategies for heart failure and atrial fibrillation. He is also a member of several steering committees for large multicenter research studies. Much of his current efforts are focused on healthcare redesign, digital health and medical device innovations. Dr. Singh has served as an International Associate editor for the European Heart Journal (2012-2015) and Deputy Editor of the Journal of American College of Cardiology: Clinical EP (2015-2020). He serves on the editorial board of several medical journals and is currently the Editor-in-chief of the Current Treatment Options in Cardiovascular Medicine. Dr. Singh has over 350 publications inclusive of original research articles, textbook chapters, review articles and editorials. He has edited two books on: i) Imaging in Electrophysiology and ii) Update on Cardiac Resynchronization Therapy.
Links Supporting This Episode:
